Immunomodulation of atherosclerosis with a vaccine
Prediman K Shah*, Kuang-Yuh Chyu, Gunilla N Fredrikson and Jan Nilsson
Correspondence *Cardiology Division, Cedars Sinai Medical Center, Suite 5531, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
Email shahp@cshs.org
Although vaccination has so far been used mainly for infectious disease, the varied roles of the immune system in atherosclerosis present the possibility of a vaccine being developed against this prevalent disease. Here, Shah and colleagues discuss some of the background and advances being made in this field.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
A protective player in the vascular response to injuryNature Medicine News and Views (01 Jun 2001)
RESEARCH
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDLNature Medicine Article (01 Jun 2003)
See all 41 matches for Research